Correlation Between BioAffinity Technologies, and Spectral Med
Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies, and Spectral Med at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies, and Spectral Med into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between bioAffinity Technologies, and Spectral Med, you can compare the effects of market volatilities on BioAffinity Technologies, and Spectral Med and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies, with a short position of Spectral Med. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies, and Spectral Med.
Diversification Opportunities for BioAffinity Technologies, and Spectral Med
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between BioAffinity and Spectral is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies, and Spectral Med in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spectral Med and BioAffinity Technologies, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies, are associated (or correlated) with Spectral Med. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spectral Med has no effect on the direction of BioAffinity Technologies, i.e., BioAffinity Technologies, and Spectral Med go up and down completely randomly.
Pair Corralation between BioAffinity Technologies, and Spectral Med
Given the investment horizon of 90 days bioAffinity Technologies, is expected to under-perform the Spectral Med. But the stock apears to be less risky and, when comparing its historical volatility, bioAffinity Technologies, is 1.48 times less risky than Spectral Med. The stock trades about -0.45 of its potential returns per unit of risk. The Spectral Med is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest 32.00 in Spectral Med on October 24, 2024 and sell it today you would earn a total of 10.00 from holding Spectral Med or generate 31.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 94.74% |
| Values | Daily Returns |
bioAffinity Technologies, vs. Spectral Med
Performance |
| Timeline |
| bioAffinity Technologies, |
| Spectral Med |
BioAffinity Technologies, and Spectral Med Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioAffinity Technologies, and Spectral Med
The main advantage of trading using opposite BioAffinity Technologies, and Spectral Med positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies, position performs unexpectedly, Spectral Med can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spectral Med will offset losses from the drop in Spectral Med's long position.| BioAffinity Technologies, vs. Nuvalent | BioAffinity Technologies, vs. Arcellx | BioAffinity Technologies, vs. Vaxcyte | BioAffinity Technologies, vs. Crinetics Pharmaceuticals |
| Spectral Med vs. Avricore Health | Spectral Med vs. bioAffinity Technologies, | Spectral Med vs. BioMark Diagnostics | Spectral Med vs. Mainz Biomed BV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |